Michael N. Alonso
About Michael N. Alonso
Michael N. Alonso's Title and Current Role
Michael N. Alonso serves as the Vice President of Immunology & Pharmacology. In this capacity, he focuses on translating scientific discoveries into innovative therapies. He brings deep expertise in myeloid biology and drug discovery, which plays a crucial role in developing new therapeutic approaches for cancer patients.
Michael N. Alonso's Background in Biotechnology
Michael N. Alonso is a well-published scientist with more than a decade of research and translational experience in immunology, neuroscience, and transplant biology. He co-founded Bolt Biotherapeutics and was the lead scientist at a Bay Area biotechnology start-up company. His background also includes holding leadership roles at Stanford University, where he contributed to significant advancements in his fields of expertise.
Michael N. Alonso's Education and Academic Achievements
Michael N. Alonso earned his Ph.D. from Stanford University School of Medicine and received a Certificate in Entrepreneurship from the Stanford Graduate School of Business. He graduated with distinction from the University of Illinois at Urbana-Champaign, where he obtained his Bachelor of Science degree in molecular and cellular biology. His comprehensive academic background underpins his extensive experience in the biotechnology sector.
Michael N. Alonso's Innovations and Contributions
Michael N. Alonso is the co-inventor of Bolt Biotherapeutics' proprietary ISAC platform, which represents a significant advancement in the field of biotherapeutics. He has consistently emphasized the importance of translating scientific discoveries into therapies that help cancer patients become survivors. His work in immunology and drug discovery has made notable contributions to developing new cancer treatments.